Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

This study has been completed.
Information provided by:
AmpliMed Corporation Identifier:
First received: May 17, 2006
Last updated: September 14, 2010
Last verified: September 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)